Approval · Notice of Compliance 32638 · 2024
EYLEA HD: Notice of Compliance 32638
Issued February 2, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32638
- Date
- February 2, 2024
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new strength and addition of alternate dosing regimen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EYLEA HD | 02545004 | Marketed |
Medicinal ingredients
- AFLIBERCEPT 8 MG per 0.07ML